How Can AI-Assisted Image Analysis Boost Productivity in Preclinical Research, Including GLP?
About this webinar
Digital pathology with artificial intelligence (AI)-assisted image analysis has become increasingly available for clinical diagnostics, veterinary diagnostics, preclinical research and drug development. In this webinar, the attendees will gain insights into how it can enhance the precision and effectiveness of pathologists’ workflows with particular emphasis on the preclinical research and drug development environment.
The expert speakers will discuss how AI-based image analysis can support pathologists and other experts, throughout their workflows, with a focus on preclinical procedures — from image quality control support, assistive decision-making and the quantification of morphological features mainly in the preclinical setting, including studies conducted under the good laboratory practice (GLP) framework.
After this webinar, attendees will understand:
- The benefits of image analysis in a cloud-based and study-centric workflow
- Things to consider when integrating software and quantitative data
- The next advancements in the field of preclinical research and drug development
Register for this webinar today to learn best practices for implementing AI-assisted image analysis into the preclinical workflow.
Who should attend
- Pathologists working in preclinical R&D
- Researchers with an interest in AI and image analysis
- Pathology fellows and trainees with an interest in AI
- Industry professionals involved in pathology image analysis
What you will learn
- How AI-assisted image analysis improves the accuracy and efficiency in the preclinical workflow
- What to consider when implementing AI into the workflow
- How AI-assisted image analysis works under the GLP framework
Featured Speakers
Richard Haworth
Richard Haworth is board-certified in veterinary pathology (FRCPath, DipECVP) and toxicology (Diplomate of the American Board of Toxicology). He qualified in veterinary medicine from the University of Cambridge and completed a DPhil at Oxford in experimental pathology and immunology. Richard has senior leadership experience in pharma at AstraZeneca and GSK, and he is the Founder of RosettaPath, a science-based pathology consultancy.
Richard Fox
Richard Fox, BvetMed, DipECVP, MRCVS, joined Aiforia in 2023 as a Veterinary Pathologist. He is a board-certified pathologist and scientist by training at the University of Liverpool, UK. His research areas of expertise in pathology include dermatopathology, oncology, and more recently, the implementation of AI in the diagnostic environment.
Partner for this event
Aiforia
Aiforia equips pathologists and scientists in clinical, pre-clinical, and academic labs with powerful deep learning AI and cloud-based technology. Aiforia’s solutions strive to increase the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology. Aiforia’s mission is to transform pathology image analysis with AI, enabling better care for each patient. www.aiforia.com